Lunken Lab

Could an artificial gut revolutionize how we treat inflammatory bowel disease?

We are excited to share a new article from UBC’s The Next Big Question series, featuring the Lunken Lab’s pioneering research.

Using Canada’s first artificial gut simulator, the MiniBioReactor Array (MBRA), our lab studies patient-derived gut microbial communities in a controlled laboratory environment to investigate how they respond to different treatments. This innovative approach could help deepen our understanding of inflammatory bowel disease (IBD) and support the development of more personalized treatment strategies.